<DOC>
	<DOCNO>NCT01454700</DOCNO>
	<brief_summary>The purpose study investigate whether combination insulin pump therapy continue glucose monitoring ( CGM ) superior multiple daily insulin injection prevent progression albuminuria patient type 1 diabetes</brief_summary>
	<brief_title>Effect CSII CGM Progression Late Diabetic Complications</brief_title>
	<detailed_description>80 type 1 diabetic patient kidney function ( GFR &gt; 45 ml/min ) , urine albumin excretion least 30 mg/day HbA1c 7.5-13.0 % randomise either multiple daily insulin injection ( control group ) insulin pump therapy plus continued glucose monitoring ( CGM ) ( intervention group ) . Patients must stable RAAS blockade enter study . Before study initiate patient receive education intensive diabetes treatment self-care include carbohydrate counting . Patients return clinic 1,3,6,9 , 12 month measurement urine albumine excretion , clinical examination include blood pressure , CGM sensor reading , four-point self monitor blood glucose ( SMBG ) profile , blood sample fulfillment questionnaire ass quality life . At entry 12 month , eye fundus foto , 24-hour blood pressure , GFR , carotis intima medium thickness ( CIMT ) also evaluate .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1875 year age , Type 1 diabetes accord WHO criterion , Urin albumine &gt; 30 mg/g ( albumine/creatinine ratio ) , HbA1c &gt; 7.5 &lt; 13.0 % , No change RAAS block treatment least 4 week prior screen . Kidney disease diabetic nephropathy , Recurrence severe hypoglycaemia hypoglycaemia unawareness judge investigator , Use insulin pump within 12 month , Acute myocardial infarction within 3 month , Severe arteriosclerosis judge investigator , Heart failure ( NYHA class 3 4 ) , Abuse alcohol drug , Any cancer diagnosis unless remission least 5 year prior screen , Participation intervention study , Pregnant lactate woman , Any disease , condition type treatment judge investigator render patient ineligible participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Type 1 diabetes mellitus</keyword>
	<keyword>Albuminuria</keyword>
	<keyword>Late diabetes complication</keyword>
	<keyword>CSII</keyword>
	<keyword>CGM</keyword>
	<keyword>Glycaemic control</keyword>
</DOC>